Form 8-K - Current report:
SEC Accession No. 0001193125-24-220131
Filing Date
2024-09-17
Accepted
2024-09-17 07:16:00
Documents
15
Period of Report
2024-09-17
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d877205d8k.htm   iXBRL 8-K 26638
2 EX-99.1 d877205dex991.htm EX-99.1 9476
6 GRAPHIC g877205g0917072805094.jpg GRAPHIC 3679
  Complete submission text file 0001193125-24-220131.txt   175273

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vigl-20240917.xsd EX-101.SCH 2859
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vigl-20240917_lab.xml EX-101.LAB 19500
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vigl-20240917_pre.xml EX-101.PRE 12162
18 EXTRACTED XBRL INSTANCE DOCUMENT d877205d8k_htm.xml XML 3960
Mailing Address 100 FORGE ROAD SUITE 700 WATERTOWN MA 02472
Business Address 100 FORGE ROAD SUITE 700 WATERTOWN MA 02472 857-254-4445
Vigil Neuroscience, Inc. (Filer) CIK: 0001827087 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41200 | Film No.: 241302582
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)